TY - JOUR
T1 - Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6 months of age
AU - Bambul Heck, P.
AU - Eicken, A.
AU - Kasnar-Samprec, J.
AU - Ewert, P.
AU - Hager, A.
N1 - Publisher Copyright:
© 2016 Elsevier Ireland Ltd
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Background Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6 months and whether there are risk factors for developing PAH. Methods Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6 months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of ≥ 25 mm Hg or tricuspid regurgitation jet velocity of ≥ 3.5 m/s. Results In 228 patients (median age at shunt closure 4.0 years, range 0.5–69) and 174 complete follow-up data (median follow-up 3.7 years, range 0.5–39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79 months. Three patients are still on vasodilator treatment 1, 2.6 and 6 years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemodynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH. Conclusion With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment.
AB - Background Pulmonary arterial hypertension (PAH) is virtually absent after closure of ventricular septal defect (VSD) in the first six months of life. However the prevalence of PAH in patients, who underwent VSD closure later, is not clear. The aim of this study was to analyse the prevalence of PAH after a successful VSD closure after the age of 6 months and whether there are risk factors for developing PAH. Methods Echocardiographic and right heart catheter data of patients with VSD or complete atrioventricular septal defect, who underwent VSD closure after the age of 6 months in our institution between 01/2005 and 06/2014, were retrospectively analyzed. PAH was defined as mean pulmonary arterial pressure (mPAP) of ≥ 25 mm Hg or tricuspid regurgitation jet velocity of ≥ 3.5 m/s. Results In 228 patients (median age at shunt closure 4.0 years, range 0.5–69) and 174 complete follow-up data (median follow-up 3.7 years, range 0.5–39.4), 9 patients needed pulmonary vasodilator therapy after shunt closure, 4 of them temporarily for up to 79 months. Three patients are still on vasodilator treatment 1, 2.6 and 6 years after surgery, other two were lost to follow-up. Another 6 patients with preoperatively borderline hemodynamics due to elevated mPAP and pulmonary vascular resistance, recovered well without signs of postoperative PAH. Conclusion With the current practice for safe late VSD closure, PAH is very rare at least in the first years of follow-up. In most patients with perioperative PAH, this condition appears to be transient and shows good response on pulmonary vasodilator treatment.
KW - Pulmonary arterial hypertension
KW - VSD
UR - http://www.scopus.com/inward/record.url?scp=85006253375&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.11.056
DO - 10.1016/j.ijcard.2016.11.056
M3 - Article
C2 - 27866021
AN - SCOPUS:85006253375
SN - 0167-5273
VL - 228
SP - 313
EP - 318
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -